SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001558370-16-006732
Filing Date
2016-07-22
Accepted
2016-07-22 16:15:43
Documents
5
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A bpmc-20160331x10qa.htm 10-Q/A 65033
2 EX-10.1 bpmc-20160331ex101774f59.htm EX-10.1 1169469
3 EX-10.2 bpmc-20160331ex1025287b1.htm EX-10.2 1695069
4 EX-31.1 bpmc-20160331ex311dc397b.htm EX-31.1 8447
5 EX-31.2 bpmc-20160331ex3128838b5.htm EX-31.2 8453
  Complete submission text file 0001558370-16-006732.txt   2947467
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37359 | Film No.: 161779879
SIC: 2834 Pharmaceutical Preparations